Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 107

1.

Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes.

Fernández-Barat L, Ben-Aicha S, Motos A, Vila J, Marco F, Rigol M, Muñoz L, Li Bassi G, Ferrer M, Torres A.

Sci Rep. 2018 Aug 9;8(1):11906. doi: 10.1038/s41598-018-30494-7.

2.

Epidemiology of ICU-acquired pneumonia.

Ferrer M, Torres A.

Curr Opin Crit Care. 2018 Aug 7. doi: 10.1097/MCC.0000000000000536. [Epub ahead of print]

PMID:
30080701
3.

Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study.

Moreno G, Rodríguez A, Reyes LF, Gomez J, Sole-Violan J, Díaz E, Bodí M, Trefler S, Guardiola J, Yébenes JC, Soriano A, Garnacho-Montero J, Socias L, Del Valle Ortíz M, Correig E, Marín-Corral J, Vallverdú-Vidal M, Restrepo MI, Torres A, Martín-Loeches I; on Behalf GETGAG Study Group.

Intensive Care Med. 2018 Aug 3. doi: 10.1007/s00134-018-5332-4. [Epub ahead of print]

PMID:
30074052
4.

Acute respiratory distress syndrome in mechanically ventilated patients with community-acquired pneumonia.

Cilloniz C, Ferrer M, Liapikou A, Garcia-Vidal C, Gabarrus A, Ceccato A, Puig de La Bellacasa J, Blasi F, Torres A.

Eur Respir J. 2018 Mar 29;51(3). pii: 1702215. doi: 10.1183/13993003.02215-2017. Print 2018 Mar.

PMID:
29545274
5.

Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients.

Ferrer M, Travierso C, Cilloniz C, Gabarrus A, Ranzani OT, Polverino E, Liapikou A, Blasi F, Torres A.

PLoS One. 2018 Jan 25;13(1):e0191721. doi: 10.1371/journal.pone.0191721. eCollection 2018.

6.

Adjuvant therapies in critical care: steroids in community-acquired pneumonia.

Torres A, Ferrer M, Niederman MS.

Intensive Care Med. 2018 Apr;44(4):478-481. doi: 10.1007/s00134-017-4967-x. Epub 2017 Oct 25. No abstract available.

PMID:
29071427
7.

Diagnostic Value of Endotracheal Aspirates Sonication on Ventilator-Associated Pneumonia Microbiologic Diagnosis.

Fernández-Barat L, Motos A, Ranzani OT, Bassi GL, Aguilera Xiol E, Senussi T, Travierso C, Chiurazzi C, Idone F, Muñoz L, Vila J, Ferrer M, Pelosi P, Blasi F, Antonelli M, Torres A.

Microorganisms. 2017 Sep 20;5(3). pii: E62. doi: 10.3390/microorganisms5030062.

8.

Evaluation of the 2016 Infectious Diseases Society of America/American Thoracic Society Guideline Criteria for Risk of Multidrug-Resistant Pathogens in Patients with Hospital-acquired and Ventilator-associated Pneumonia in the ICU.

Ekren PK, Ranzani OT, Ceccato A, Li Bassi G, Muñoz Conejero E, Ferrer M, Niederman MS, Torres A.

Am J Respir Crit Care Med. 2018 Mar 15;197(6):826-830. doi: 10.1164/rccm.201708-1717LE. No abstract available.

PMID:
28902529
9.

Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure.

Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, Navalesi P Members Of The Steering Committee, Antonelli M, Brozek J, Conti G, Ferrer M, Guntupalli K, Jaber S, Keenan S, Mancebo J, Mehta S, Raoof S Members Of The Task Force.

Eur Respir J. 2017 Aug 31;50(2). pii: 1602426. doi: 10.1183/13993003.02426-2016. Print 2017 Aug. Review.

PMID:
28860265
10.

Risk Factors for Noninvasive Ventilation Failure in Critically Ill Subjects With Confirmed Influenza Infection.

Rodríguez A, Ferri C, Martin-Loeches I, Díaz E, Masclans JR, Gordo F, Sole-Violán J, Bodí M, Avilés-Jurado FX, Trefler S, Magret M, Moreno G, Reyes LF, Marin-Corral J, Yebenes JC, Esteban A, Anzueto A, Aliberti S, Restrepo MI; Grupo Español de Trabajo Gripe A Grave (GETGAG)/Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC) Working Group; 2009-2015 H1N1 SEMICYUC Working Group investigators.

Respir Care. 2017 Oct;62(10):1307-1315. doi: 10.4187/respcare.05481. Epub 2017 Jul 11.

PMID:
28698265
11.

Discontinuing noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations: a randomised controlled trial.

Sellares J, Ferrer M, Anton A, Loureiro H, Bencosme C, Alonso R, Martinez-Olondris P, Sayas J, Peñacoba P, Torres A.

Eur Respir J. 2017 Jul 5;50(1). pii: 1601448. doi: 10.1183/13993003.01448-2016. Print 2017 Jul.

PMID:
28679605
12.

Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial.

Ceccato A, Cilloniz C, Ranzani OT, Menendez R, Agusti C, Gabarrus A, Ferrer M, Sibila O, Niederman MS, Torres A.

PLoS One. 2017 Jun 15;12(6):e0178022. doi: 10.1371/journal.pone.0178022. eCollection 2017.

13.

New Sepsis Definition (Sepsis-3) and Community-acquired Pneumonia Mortality. A Validation and Clinical Decision-Making Study.

Ranzani OT, Prina E, Menéndez R, Ceccato A, Cilloniz C, Méndez R, Gabarrus A, Barbeta E, Bassi GL, Ferrer M, Torres A.

Am J Respir Crit Care Med. 2017 Nov 15;196(10):1287-1297. doi: 10.1164/rccm.201611-2262OC.

PMID:
28613918
14.

Noninvasive Ventilation with Helium/Oxygen in Chronic Obstructive Pulmonary Disease Exacerbations. When Physiologic Improvement Does Not Translate into Clinical Benefit.

Ferrer M, Torres A.

Am J Respir Crit Care Med. 2017 Apr 1;195(7):843-844. doi: 10.1164/rccm.201610-2102ED. No abstract available.

PMID:
28362203
15.

Antibiotic therapy prior to hospital admission is associated with reduced septic shock and need for mechanical ventilation in patients with community-acquired pneumonia.

Amaro R, Sellarés J, Polverino E, Cillóniz C, Ferrer M, Fernández-Barat L, Mensa J, Niederman MS, Torres A.

J Infect. 2017 May;74(5):442-449. doi: 10.1016/j.jinf.2017.01.009. Epub 2017 Jan 24.

PMID:
28130142
16.

Non-invasive ventilation in hypoxemic acute respiratory failure: is it still possible?

Girault C, Ferrer M, Torres A.

Intensive Care Med. 2017 Feb;43(2):243-245. doi: 10.1007/s00134-016-4661-4. Epub 2017 Jan 19. Review. No abstract available.

PMID:
28102438
17.

Seasonality of pathogens causing community-acquired pneumonia.

Cilloniz C, Ewig S, Gabarrus A, Ferrer M, Puig de la Bella Casa J, Mensa J, Torres A.

Respirology. 2017 May;22(4):778-785. doi: 10.1111/resp.12978. Epub 2017 Jan 17.

PMID:
28093834
18.

Pneumonia in 2016: towards better care.

Torres A, Ranzani OT, Ferrer M.

Lancet Respir Med. 2016 Dec;4(12):949-951. doi: 10.1016/S2213-2600(16)30387-3. Epub 2016 Nov 22. No abstract available.

PMID:
27890504
19.

Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.

Fernández-Barat L, Ferrer M, De Rosa F, Gabarrús A, Esperatti M, Terraneo S, Rinaudo M, Li Bassi G, Torres A.

J Infect. 2017 Feb;74(2):142-152. doi: 10.1016/j.jinf.2016.11.008. Epub 2016 Nov 16.

PMID:
27865895
20.

Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome.

Álvarez-Lerma F, Marín-Corral J, Vila C, Masclans JR, González de Molina FJ, Martín Loeches I, Barbadillo S, Rodríguez A; H1N1 GETGAG/SEMICYUC Study Group.

Crit Care. 2016 Oct 23;20(1):337.

Supplemental Content

Loading ...
Support Center